Overview
An Extension Study of Enclomiphene Citrate in the Treatment of Men With Secondary Hypogonadism
Status:
Completed
Completed
Trial end date:
2014-04-01
2014-04-01
Target enrollment:
0
0
Participant gender:
Male
Male
Summary
To determine the safety profile of Androxal in men with secondary hypogonadism.Phase:
Phase 3Accepts Healthy Volunteers?
NoDetails
Lead Sponsor:
Repros Therapeutics Inc.Treatments:
Citric Acid
Clomiphene
Enclomiphene
Zuclomiphene
Criteria
Inclusion Criteria:• Successful completion of either ZA-301 or ZA-302
Exclusion Criteria:
• Any condition which, in the opinion of the Investigator, would make the Subject an
unsuitable candidate for enrollment in the study